Literature DB >> 21353092

Venous Doppler evaluation of the growth-restricted fetus.

Ahmet Alexander Baschat1.   

Abstract

Evaluation of venous Doppler parameters has significantly contributed to the understanding of the vascular mechanisms that lead to fetal growth restriction (FGR) and subsequent fetal deterioration in the setting of progressive placental dysfunction. Venous redistribution of umbilical venous blood flow away from the fetal liver precedes fetal growth delay. Venous Doppler examination allows adjustment of monitoring intervals in recognition of accelerating fetal deterioration. The timing of delivery in early-onset FGR remains challenging because gestational age has an overriding effect on the neonatal outcome until the late second trimester and randomized trials of specific delivery triggers are lacking.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353092     DOI: 10.1016/j.clp.2010.12.001

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

1.  Fetal echocardiography and pulsed-wave Doppler ultrasound in a rabbit model of intrauterine growth restriction.

Authors:  Ryan Hodges; Masayuki Endo; Andre La Gerche; Elisenda Eixarch; Philip DeKoninck; Vessilina Ferferieva; Jan D'hooge; Euan M Wallace; Jan Deprest
Journal:  J Vis Exp       Date:  2013-06-29       Impact factor: 1.355

2.  Effects of antenatal magnesium sulfate treatment on cerebral blood flow velocities in preterm neonates.

Authors:  E Y Imamoglu; T Gursoy; G Karatekin; F Ovali
Journal:  J Perinatol       Date:  2014-01-30       Impact factor: 2.521

Review 3.  Advanced MR imaging of the placenta: Exploring the in utero placenta-brain connection.

Authors:  Nickie Niforatos Andescavage; Adre du Plessis; Catherine Limperopoulos
Journal:  Semin Perinatol       Date:  2015-03-09       Impact factor: 3.300

Review 4.  The placental pursuit for an adequate oxidant balance between the mother and the fetus.

Authors:  Emilio A Herrera; Bernardo Krause; German Ebensperger; Roberto V Reyes; Paola Casanello; Mauro Parra-Cordero; Anibal J Llanos
Journal:  Front Pharmacol       Date:  2014-06-24       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.